Abstract
Patients are considered to be at high risk of cardiovascular events if they have diabetes, chronic kidney disease, stroke, established coronary artery disease, or a coronary artery disease equivalent. Blood pressure-lowering therapy has been shown to reduce cardiovascular events in these patients significantly. Identification of high-risk patients by global risk evaluation is recommended for every hypertensive patient. Treatment of hypertension in high-risk patients with an angiotensin-converting enzyme inhibitor or an angiotensin receptor antagonist, with or without addition of a dihydropyridine calcium channel antagonist, is a reasonable approach based on current clinical trials. © 2011 Tsai, publisher and licensee Dove Medical Press Ltd.
Author supplied keywords
Cite
CITATION STYLE
Tsai, W. C. (2011). Treatment options for hypertension in high-risk patients. Vascular Health and Risk Management. DOVE Medical Press Ltd. https://doi.org/10.2147/VHRM.S11235
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.